PHR vs HCAT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
PHR
HCAT
Investment Advisor Scores
HCAT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PHR | HCAT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.0192 | 10 | HCAT |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 10.4% | -12.7% | PHR |
| Earnings Growth | 200.0% | 0.0% | PHR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 46.1/100 | 56.9/100 | HCAT |
| Profit Margin | 2.1% | -90.6% | PHR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | BUY | HCAT |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PHR
NeutralMixed signals - no dominant trend phase, RSI 73
HCAT
DistributionPrice near a flattening SMA50 (slope -7.8%) with fading momentum, RSI 48
Fundamentals Snapshot
| Metric | PHR | HCAT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 8.1 | 232.0 |
| Trailing P/E | 66.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | -0.1% |
| Gross Margin | 0.7% | 0.5% |
| Operating Margin | 0.1% | -0.1% |
| EPS | 0.18 | -3.69 |
| Dividend Yield | — | — |